- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06378320
eHealth for Breastfeeding Support - the HOTSPOT Trial
This is a voluntary research study to test use of a phone app that is intended to support breastfeeding specifically for African American and Black people. This is called a "pilot" study because the app is still in development. The goal of this research is to see if mothers use the app more when they receive text "nudges" to look at it compared to not getting those "nudges". The research project is being conducted by Lydia Furman MD.
The purpose of the app (which is currently in clickable "wireframe" status, a "pre" app phase) is to support and promote breastfeeding specifically for mothers and fathers/partners who are African American or Black. Other breastfeeding apps have pictures mainly of White or Asian mothers and information that is not oriented toward African American mothers. This app aims to provide accurate and needed breastfeeding information that is culturally attuned.
Up to 24 participants will be enrolled at UHCMC, including up to 20 mothers. Other participants will include up to 4 African American or Black fathers/partners whose partners are interested in breastfeeding.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- University Hospital MacDonald Women's Hospital
-
Cleveland, Ohio, United States, 44103
- Ahuja Rainbow Center for Women and Children
-
Cleveland, Ohio, United States, 44103
- Passages, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Maternal participants
- Adult women who are expecting (pregnant) and between 24-34 weeks gestation
- Self-describe as African-American or Black (AA/B)
- Have a smart phone
- Receive prenatal care at either Ahuja Rainbow Center for Women and Children or MacDonald and Women's Suite 1200 at University Hospitals
- Either interested in or committed to breastfeeding for their infant
- Father/partner participants
- Father (mother/partner is expectant or delivered) or plan to become father
- Age 18 years or older
- Have a smart phone or a personal device or iPad
- Attending programming at Passages, Inc.
- Self-identified interest in how their own infant will be fed
- Self-describe as African-American or Black
Exclusion Criteria:
- Age under 18 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Maternal participants nudge group
Participants in the app "nudge" group receive access to the app and questions with app cues by text weekly prior to delivery and biweekly (every 2 weeks) after delivery through 3 months postpartum.
|
Access to App and Text messages with app related breastfeeding related question
Other Names:
|
|
Other: Maternal participants no nudge group
Participants in the app "no nudge" group receive access to the app and no questions with app cues through 3 months postpartum.
|
Access to App without Text messages with app related breastfeeding related question
Other Names:
|
|
Experimental: Father/partner participants nudge group
Participants in the app "nudge" group receive access to the app and questions with app cues by text weekly for the first 2 months and then biweekly (every 2 weeks) for another 2 months.
|
Access to App and Text messages with app related breastfeeding related question
Other Names:
|
|
Other: Father/partner participants no nudge group
Participants in the app "no nudge" group receive access to the app and no questions with app cues for 4 months.
|
Access to App without Text messages with app related breastfeeding related question
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal participants app usability score
Time Frame: Up to 3 months postpartum
|
Percentage of participants with System Usability Scale score of >78.8
|
Up to 3 months postpartum
|
|
Father/partner participants app usability score
Time Frame: Up to 4 months post-enrollment
|
Percentage of participants with System Usability Scale score of >78.8
|
Up to 4 months post-enrollment
|
|
Maternal participants app engagement score
Time Frame: Up to 3 months postpartum
|
Percentage of participants with an app interaction score of more than 1 on a 5 point scale with 1 meaning no engagement past week and 5 meaning more than daily engagement in the past week
|
Up to 3 months postpartum
|
|
Father/partner participants app engagement score
Time Frame: Up to 4 months post-enrollment
|
Percentage of participants with an app interaction score of more than 1 on a 5 point scale with 1 meaning no engagement past week and 5 meaning more than daily engagement in the past week
|
Up to 4 months post-enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal participants breastfeeding knowledge at enrollment
Time Frame: At enrollment
|
Percentage of participants with 75% or more correct responses to 4 breastfeeding knowledge questions
|
At enrollment
|
|
Maternal participants breastfeeding knowledge after app exposure
Time Frame: At 2 months postpartum
|
Percentage of participants with 75% or more correct responses to 10 breastfeeding
|
At 2 months postpartum
|
|
Father/partner participants breastfeeding knowledge at enrollment
Time Frame: At enrollment
|
Percentage of participants with 75% or more correct responses to 4 breastfeeding knowledge questions
|
At enrollment
|
|
Father/partner participants breastfeeding knowledge after app exposure
Time Frame: At 3 months post-enrollment
|
Percentage of participants with 75% or more correct responses to 10 breastfeeding
|
At 3 months post-enrollment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lydia Furman, MD, University Hospitals Cleveland Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY20240287
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Feeding
-
London School of Hygiene and Tropical MedicineFHI 360; AFRICSante; Centre MurazCompleted
-
The Hong Kong Polytechnic UniversityCompletedParents | Breast Feeding, ExclusiveHong Kong
-
Loma Linda UniversityNot yet recruitingPregnancy Related | Breast Feeding, ExclusiveUnited States
-
University of FloridaCompleted
-
Emel GÜÇLÜ CİHANKahramanmaras Sutcu Imam UniversityRecruitingBreast Feeding | Primiparity | Exclusive Breast Feeding | Maternal-Fetal AttachmentTurkey (Türkiye)
-
Danone NutriciaCompletedBreast Feeding | Breast Milk ExpressionChina
-
University of TurkuCompleted
-
Sakarya UniversityNot yet recruitingBreast Feeding | Feeding BehaviorTurkey
-
University of Maryland, BaltimoreWithdrawnBreast Pumping | Human Milk/BreastfeedingUnited States
-
Cumhuriyet UniversityCumhuriyet University HospitalCompletedBreast-feeding | Kangaroo Care | Comfort in Neonates | Pain in NewbornsTurkey (Türkiye)
Clinical Trials on App access and Text message
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA)CompletedNicotine Dependence | Nicotine Use Disorder | Nicotine Vaping | Vaping | Nicotine AddictionUnited States
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA)RecruitingNicotine Dependence | Tobacco-Related CarcinomaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHealthy VolunteersUnited States
-
University of California, San FranciscoUniversity of WashingtonCompleted
-
University of WashingtonUniversity of Illinois at Chicago; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency Syndrome | Circumcision, Male | Patient Compliance | Cellular PhoneKenya
-
Texas Tech University Health Sciences CenterTexas Tech UniversityCompletedBreast Cancer FemaleUnited States
-
University of WashingtonUniversity of California, San Francisco; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency SyndromeKenya
-
Women and Infants Hospital of Rhode IslandCompletedPreeclampsia | Gestational Hypertension | Chronic Hypertension Complicating PregnancyUnited States
-
Columbia UniversityPfizerCompletedVaccinationUnited States
-
University of Maryland, BaltimoreMerck Sharp & Dohme LLCTerminatedHPV VaccinesUnited States